1. Home
  2. RXT vs MCRB Comparison

RXT vs MCRB Comparison

Compare RXT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$1.23

Market Cap

481.5M

Sector

Technology

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$8.84

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
MCRB
Founded
1998
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.5M
139.7M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
RXT
MCRB
Price
$1.23
$8.84
Analyst Decision
Hold
Buy
Analyst Count
6
2
Target Price
$1.71
$14.00
AVG Volume (30 Days)
7.4M
39.3K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
N/A
EPS
N/A
0.64
Revenue
$2,685,700,000.00
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.35
N/A
P/E Ratio
N/A
$13.45
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$0.36
52 Week High
$2.74
$29.98

Technical Indicators

Market Signals
Indicator
RXT
MCRB
Relative Strength Index (RSI) 47.56 46.20
Support Level $1.16 $7.98
Resistance Level $1.32 $9.53
Average True Range (ATR) 0.14 0.59
MACD 0.02 0.06
Stochastic Oscillator 68.27 40.59

Price Performance

Historical Comparison
RXT
MCRB

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: